Amneal Pharmaceuticals (AMRX) PT Raised to $7 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St set to open higher as oil slips; telecoms hit by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $19.65 --0%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 28
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 28
Join SI Premium – FREE
BTIG analyst Timothy Chiang raised the price target on Amneal Pharmaceuticals (: AMRX) to $7.00 (from $5.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amneal to Report Third Quarter 2026 Results on November 3, 2026
- LG Energy Solution (373220:KS) PT Raised to KRW470,000 at JPMorgan
- Fast Retailing Co Ltd. (9983:JP) (FRCOY) PT Raised to JPY87,000 at CLSA
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
